BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15330182)

  • 1. Antitumour effectiveness of hyperthermia is potentiated by local application of electric pulses to LPB tumours in mice.
    Karner KB; Lesnicar H; Cemazar M; Sersa G
    Anticancer Res; 2004; 24(4):2343-8. PubMed ID: 15330182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of bioreductive drug tirapazamine is increased by application of electric pulses in SA-1 tumours in mice.
    Cemazar M; Parkins CS; Holder AL; Kranjc S; Chaplin DJ; Sersa G
    Anticancer Res; 2001; 21(2A):1151-6. PubMed ID: 11396155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroporation of LPB sarcoma cells in vitro and tumors in vivo increases the radiosensitizing effect of cisplatin.
    Kranjc S; Cemazar M; Grosel A; Scancar J; Sersa G
    Anticancer Res; 2003; 23(1A):275-81. PubMed ID: 12680224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of different platinum (II) analogues to human tumour cell lines in vitro and murine tumour in vivo alone or combined with electroporation.
    Cemazar M; Pipan Z; Grabner S; Bukovec N; Sersa G
    Anticancer Res; 2006; 26(3A):1997-2002. PubMed ID: 16827135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin.
    Cemazar M; Miklavcic D; Scancar J; Dolzan V; Golouh R; Sersa G
    Br J Cancer; 1999 Mar; 79(9-10):1386-91. PubMed ID: 10188880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
    Jordan A; Scholz R; Wust P; Fähling H; Krause J; Wlodarczyk W; Sander B; Vogl T; Felix R
    Int J Hyperthermia; 1997; 13(6):587-605. PubMed ID: 9421741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined electric field and ultrasound therapy as a novel anti-tumour treatment.
    Larkin J; Soden D; Collins C; Tangney M; Preston JM; Russell LJ; McHale AP; Dunne C; O'Sullivan GC
    Eur J Cancer; 2005 Jun; 41(9):1339-48. PubMed ID: 15913991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma.
    Herman TS; Teicher BA
    Cancer Res; 1988 May; 48(10):2693-7. PubMed ID: 3359430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of cell electrofusion in vitro and in vivo is cell line dependent.
    Salomskaite-Davalgiene S; Cepurniene K; Satkauskas S; Venslauskas MS; Mir LM
    Anticancer Res; 2009 Aug; 29(8):3125-30. PubMed ID: 19661325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor blood flow modifying effect of electrochemotherapy with bleomycin.
    Sersa G; Cemazar M; Miklavcic D; Chaplin DJ
    Anticancer Res; 1999; 19(5B):4017-22. PubMed ID: 10628347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.
    Hokland SL; Horsman MR
    Int J Hyperthermia; 2007 Nov; 23(7):599-606. PubMed ID: 18038290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
    Kozin SV; Kozina LV
    Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin.
    Sersa G; Krzic M; Sentjurc M; Ivanusa T; Beravs K; Kotnik V; Coer A; Swartz HM; Cemazar M
    Br J Cancer; 2002 Oct; 87(9):1047-54. PubMed ID: 12434299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antitumor effect of hyperthermia combined with fluorouracil and its analogues.
    Harada S; Ping L; Obara T; Oikawa H; Miyata M; Matsuo M; Takahashi T; Yanagisawa T
    Radiat Res; 1995 May; 142(2):232-41. PubMed ID: 7724740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells and tumors in mice.
    Kranjc S; Cemazar M; Grosel A; Sentjurc M; Sersa G
    BMC Cancer; 2005 Sep; 5():115. PubMed ID: 16168056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice.
    Sersa G; Cemazar M; Miklavcic D
    Cancer Res; 1995 Aug; 55(15):3450-5. PubMed ID: 7614485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new antitumour treatment combining radiation and electric pulses.
    Engström PE; Persson BR; Brun A; Salford LG
    Anticancer Res; 2001; 21(3B):1809-15. PubMed ID: 11497263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of hyperthermia in regional alkylating agent chemotherapy.
    Abdel-Wahab OI; Grubbs E; Viglianti BL; Cheng TY; Ueno T; Ko S; Rabbani Z; Curtis S; Pruitt SK; Dewhirst MW; Tyler DS
    Clin Cancer Res; 2004 Sep; 10(17):5919-29. PubMed ID: 15355925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimisation of pulse parameters in vitro for in vivo electrochemotherapy.
    Lebar AM; Sersa G; Kranjc S; Groselj A; Miklavcic D
    Anticancer Res; 2002; 22(3):1731-6. PubMed ID: 12168862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.